Celularity (CELU) Liabilities and Shareholders Equity (2018 - 2025)

Celularity (CELU) has reported Liabilities and Shareholders Equity for 8 consecutive years, with $336000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 99.75% year-over-year to $336000.0; the TTM figure through Dec 2025 stood at $363.7 million (down 32.75% YoY), while the FY2025 annual figure was $336000.0, down 99.75% from the prior year.
• Liabilities and Shareholders Equity fell to $336000.0 in Q4 2025 per CELU's latest filing, from $114.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $448.3 million in Q3 2021 and bottomed at $336000.0 in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $239.9 million across 5 years, with a median of $150.5 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 234.33% — and 2025, when it slumped 99.75%.
• Celularity's Liabilities and Shareholders Equity stood at $414.1 million in 2021, then dropped by 3.15% to $401.1 million in 2022, then tumbled by 64.12% to $143.9 million in 2023, then declined by 7.79% to $132.7 million in 2024, then plunged by 99.75% to $336000.0 in 2025.
• Business Quant data shows CELU's Liabilities and Shareholders Equity at $336000.0 in Q4 2025, $114.2 million in Q3 2025, and $120.3 million in Q2 2025.